The Form 4 filing, an SEC report of an insider’s stock activity, was filed on November 12, 2026. It covers the November 9 sale, three days earlier. The seller’s listed title is executive vice president and president, LSG.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-09 |
| Date of Latest Transaction | 2026-11-09 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 1,400 |
| Price | $385.63 |
| Total Transaction Value | $539,876.40 |
| Insider | |
| Ticker Symbol | BIO BIO.B |
| Company | BIO-RAD LABORATORIES, INC. |
| Insider Name | BARRY JAMES |
| Insider Title | EVP, President, LSG |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 624.68 |
| Position Size Change | 69.15% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a stock sale, reported under SEC transaction code S. The record lists one transaction. The available details do not establish where the shares were sold.
What was the average price of the transaction?
The average price was $385.626 per share, shown as $385.63 when rounded to cents. The more precise price matches the reported total value for the shares sold.
How did this transaction affect the insider's holdings?
The insider sold 1,400 shares and reported 624.682 shares owned afterward. That remaining balance rounds to 624.68 shares. The sale accounted for 69.15% of the shares held before the sale.
What's the total transaction value?
The total transaction value was $539,876.40. This amount covers the single reported sale on November 9, 2026.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement for this sale. Filing footnote text was not available for this report, so further terms or explanations remain unknown. The available details do not establish why the insider sold.
For research purposes only; not investment advice.